American Journal of Cardiology
Volume 105, Issue 4 , Pages 435-440 , 15 February 2010

Hematocrit Level as a Marker of Outcome in ST-Segment Elevation Myocardial Infarction

Received 5 August 2009 ,Revised 7 October 2009 ,Accepted 7 October 2009.

References 

  1. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042–2049
  2. Carallo C, Pujia A, Irace C, De Franceschi MS, Motti C, Gnasso A. Whole blood viscosity and haematocrit are associated with internal carotid atherosclerosis in men. Coron Artery Dis. 1998;9:113–117
  3. Gagnon DR, Zhang TJ, Brand F, Kannel WB. Hematocrit and the risk of cardiovascular disease—the Framingham study: a 34-year follow-up. Am Heart J. 1994;127:674–682
  4. Wannamethee G, Perry IJ, Shaper AG. Haematocrit, hypertension and risk of stroke. J Intern Med. 1994;235:163–168
  5. Kershenovich S, Modiano M, Ewy GA. Markedly decreased coronary blood flow in secondary erythrocytosis. Am Heart J. 1992;123:521–523
  6. Lowe GD, Forbes CD. Blood rheology and thrombosis. Clin Haematol. 1981;10:343–367
  7. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. BMJ. 1973;4:576–581
  8. WHO Scientific Group. Nutritional Anemias: Report of A Scientific Group. Geneva: World Health Organization; 1968;
  9. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  10. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818–827
  11. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol. 2004;44:547–553
  12. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study. Circulation. 2006;113:2713–2723
  13. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297:2481–2488
  14. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation. 2009;119:687–698

PII: S0002-9149(09)02521-1

doi: 10.1016/j.amjcard.2009.10.016

American Journal of Cardiology
Volume 105, Issue 4 , Pages 435-440 , 15 February 2010

Article Tools

* Image Usage & Resolution